Page 17 - 2516_ISLA_Market_Report_-_Sep_2025_v6
P. 17

16                                                                                                      17

 Securities Lending Market Report | H1 2025









 Equities







 >>>  EMEA Equities

 Europe as a region has been a beneficiary of the perceived volatility in the U.S. and demonstrated strength against the   Fig 4 - S&P Global
 headwinds of U.S. trade tariffs and economic uncertainty with a strong recovery off the back of the tariff related volatility in   European Equity Market
 April. There has been increased interest from the buyside partly due to the lower ECB rate allowing borrowers to enjoy interest
 rates approximately 2% lower than that of their American counterparts. Coupled with positive sentiment, this contributed to
 a market rally and increased utilization that saw on loan balances reach a high of €225bn before the market collapsed in April   4.00  0.30
               3.90
 due to the tariff uncertainty on a global scale. European equities started the year with around €155bn on loan and peaked at   3.80  0.25
 just under €257bn and a utilization of 5.5% in the beginning of June, a 28% increase from a low of €200bn on loan in April.   3.70  0.20
 Over the full period, European equities saw a 30% growth in on loan balances for H1 while the Stoxx600 was up only 6.7%.  3.60
               3.50
 The Stoxx600 increase this period was supported by banks   In healthcare, Idorsia Limited (IDIA SW) a pharmaceutical   Lendable Value (Trillions €)  3.40  0.15  On-Loan Value (Trillions €)
 (SX7P) that was up 27.3%, utilities (SX6P) that were up 18.4%   company restructured their convertible bond debt to free up   3.30  0.10
               3.20
 and finally construction materials (SXOP), Insurance (SXIP),   CHF150mn of new funding in February this year, extending its   3.10  0.05
 industrial goods and services (SXNP) and Telecoms (SXKP) up   cash runway into 2026. Additionally, two of their new products   3.00
 14.7%, 12.9% and 12.6% respectively. Conversely, Travel &   QUVIVIQ and TRYVIO, an insomnia and hypertension drug   2.90  0.00
 Leisure, Media, Healthcare, Autos, Consumer Products and   respectively saw regulatory barriers lifted in the U.S. and   Jan 2025  Feb 2025  Mar 2025  Apr 2025  May 2025  Jun 2025
 Basic Resources exhibited declines between 2 and 8%. On   approval for expansion into China, all contributing to a 302%   Group Lendable  On-Loan Balance
 the back of the rally in the Telecoms sector, Eutelsat (ETL   spike in share price from CHF0.71 to CHF2.15 on over the
 FP) saw borrow levels averaging 17% and utilization holding   first half of this year. IDIA SW remained well utilized over the
 steady at 97%. At its peak, ETL FP surged to 35% borrow   period with average fees of 73.74%. In terms of collateral
 fee in June following a meteoric rise in the share price of   preferences, non-cash collateral continues to be favored by   Fig 5 - S&P Global
 over 390% over the week of March 10, 2025, on news that   the borrower community with non-cash balances averaging   European Equity Market Cash vs Non-Cash
 Eutelsat could potentially replace Elon Musk’s Starlink in   5x of cash balances. Our view is that this will continue as the
 Ukraine due to souring relations between Ukraine and the   lender community begins to broaden acceptable collateral sets   50.00  250.00
 U.S. administration. BT Group (BT/A LN), the UK’s leading   beyond the traditional G10 and main index equities.   45.00
 provider of telecommunications started the year at GBP1.38   40.00                                     200.00
 but increased 30% to GBP1.94 per share but continued to be   35.00
 plagued by missed earnings numbers and weak international   30.00                                      150.00
 sales and saw stable utilization but remained largely GC at   On-Loan vs Cash (Billions €)  25.00      100.00 On-Loan vs Non-Cash (Billions €)
              20.00
 20bps due to depth of supply.   15.00                                                                  50.00
              10.00

 Top Market by Value On-Loan  5.00 -  Feb 2025  Mar 2025      Apr 2025       May 2025        Jun 2025   0.00
                Jan 2025
 •  UK €39bn  •  FR €27bn  •  IT €19bn  •  ES €10bn  Group Lendable  On-Loan Balance
 •  DE €29bn  •  CH €26bn  •  SE €19bn


 Top Performing Names by Revenue
 •  IDIA SW €8mn, 57.5% utilisation, €21.6mn on loan,   •  RPI LN €2.9mn, 72,8% utilisation, €67.7mn on loan,
   vwaf 7,374bps    vwaf 862bps
 •  YUBICO SS €6.7mn, 93% utilisation, €113.9mn on loan;   •  BT/A LN €2.4mn, 47.5% util, €2.4bn on loan, vwaf 20bps
   vwaf 1,168bps
 •  INTRUM SS €2.3mn, 60.4% util, €19.1mn on loan
 •   ETL FP €5.7mn, 88.2% utilisation, €82.4mn on loan,     vwaf 2,422bps
 vwaf 1,376bps
 •  GSF NO €2.3mn, 87.6% util, €66.3mn on loan, vwaf 685bps
 •  NB2 GR €3mn, 63.2% utilisation, €42.2mn on loan,   •  AML LN €2.3mn, 86.2% util, €89.6mn on loan, vwaf 506bps
   vwaf 1,401bps
    •  ATS AV €2.2mn, 85.5% util, €30mn on loan, vwaf 1,466bps
   12   13   14   15   16   17   18   19   20   21   22